CARsgen Therapeutics Holdings Limited
科濟藥業控股有限公司

18 JUN 2021

CARsgen Therapeutics Holdings Limited is a biopharmaceutical company with operations in China and the U.S. focused on innovative CAR-T cell therapies for the treatment of hematological malignancies and solid tumors. The company has developed technologies and a product pipeline with global rights to address challenges of CAR-T cell therapies, such as improving the safety profile, enhancing the efficacy in treating solid tumors, and reducing treatment costs.

科濟藥業控股有限公司在中國及美國進行生物製藥，專注研發治療血液惡性腫瘤和實體瘤的創新CAR-T細胞療法。公司已開發新技術，並擁有一系列可於全球生產的產品線，以解決CAR-T細胞療法的各種問題，包括提高療法安全性、提高治療實體瘤的療效和降低治療成本。